Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) Income from Continuing Operations (2018 - 2025)

Historic Income from Continuing Operations for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $24.3 million.

  • TransMedics' Income from Continuing Operations rose 47711.1% to $24.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $91.8 million, marking a year-over-year increase of 18436.68%. This contributed to the annual value of $35.5 million for FY2024, which is 23964.95% up from last year.
  • According to the latest figures from Q3 2025, TransMedics' Income from Continuing Operations is $24.3 million, which was up 47711.1% from $34.9 million recorded in Q2 2025.
  • Over the past 5 years, TransMedics' Income from Continuing Operations peaked at $34.9 million during Q2 2025, and registered a low of -$25.4 million during Q3 2023.
  • Over the past 5 years, TransMedics' median Income from Continuing Operations value was -$2.6 million (recorded in 2023), while the average stood at $744263.2.
  • As far as peak fluctuations go, TransMedics' Income from Continuing Operations crashed by 24233.77% in 2023, and later soared by 131818.18% in 2024.
  • TransMedics' Income from Continuing Operations (Quarter) stood at -$12.8 million in 2021, then soared by 45.58% to -$7.0 million in 2022, then surged by 152.56% to $3.7 million in 2023, then skyrocketed by 87.58% to $6.9 million in 2024, then skyrocketed by 254.01% to $24.3 million in 2025.
  • Its last three reported values are $24.3 million in Q3 2025, $34.9 million for Q2 2025, and $25.7 million during Q1 2025.